India
141 articles related to "India"
-
U.S. Penalises India for Promoting Access to Medicines Strategies by Placing it on Trade "Watch List"
The U.S. Trade Representative's decision to place India on its annual trade "Watch List" is a bully tactic being used to punish the country for taking steps to ensure access to affordable,...
Statements, Speeches, Letters – Last updated 02 May 2013
msfaccess.org/content/us-penalises-india-promoting-access-medicines-strategies-placing-it-trade-watch-list -
As clock ticks towards agreement, EU-India free trade deal puts millions of lives at risk
Activists from across Europe stage flashmob in front of the European Parliament calling on Europe to drop harmful provisions Brussels, 9 April, 2013 - As European Commission (EC) pressure mounts...
Press Release – Last updated 09 April 2013
msfaccess.org/about-us/media-room/press-releases/clock-ticks-towards-agreement-eu-india-free-trade-deal-puts -
MSF's Leena Menghaney reacts to Novartis verdict in India
Multimedia – Last updated 04 April 2013
msfaccess.org/content/msfs-leena-menghaney-reacts-novartis-verdict-india -
BBC: Do drugs really have to be so expensive?
A liver cancer treatment is off-limits in the NHS due to its unjustifiably high price tag, but in India the same treatment is available for less than £100 a month. In this week's Scrubbing...
Op-eds & Articles – Last updated 28 March 2013
msfaccess.org/content/bbc-do-drugs-really-have-be-so-expensive -
Indian Supreme Court Delivers Verdict in Novartis Case
Decision safeguards access to affordable medicines and prevents abusive patenting of medicines New Delhi/Geneva, 1 April 2013 – The landmark decision by the Indian Supreme Court...
Press Release – Last updated 04 April 2013
msfaccess.org/about-us/media-room/press-releases/indian-supreme-court-delivers-verdict-novartis-case -
Update: Verdict in Novartis vs India case on patents and access to medicines due Monday 1 April
Médecins Sans Frontières has learnt that the verdict in Indian Supreme Court case of Novartis vs. Government of India will be handed down on Monday, 1 April 2013. The verdict will...
Web article – Last updated 26 March 2013
msfaccess.org/content/update-verdict-novartis-vs-india-case-patents-and-access-medicines-due-monday-1-april -
Letter from MSF to the Indian Prime Minister regarding access to medicines and the EU-India FTA
Geneva, 14 March 2013 Honourable Prime Minister Re: Access to medicines and the EU-India FTA Médecins Sans Frontières/Doctors Without Borders (MSF) is an independent,...
Statements, Speeches, Letters – Last updated 18 March 2013
msfaccess.org/content/letter-msf-indian-prime-minister-regarding-access-medicines-and-eu-india-fta -
India: MSF Joins Bihar State in Observing Annual Kala Azar Day
Hajipur, Bihar, March 15, 2013: International medical humanitarian organisation Médecins Sans Frontières (MSF) together with the Bihar State’s Ministry of Health has organised several...
Web article – Last updated 15 March 2013
msfaccess.org/content/india-msf-joins-bihar-state-observing-annual-kala-azar-day -
Combating Kala Azar: treatment is possible even in remote settings
Visceral leishmaniasis (VL), also known as kala azar, is a worldwide protozoal vector-borne disease, endemic in 76 countries. The annual incidence is estimated to be 250-300,000 cases, with...
Briefing – Last updated 15 March 2013
msfaccess.org/content/combating-kala-azar-treatment-possible-even-remote-settings -
India under pressure from Europe to sign off on trade deal that will harm access to medicines
DNP+, MSF urge India to reject EU demands before April deadline, protest at European Commission in Delhi New Delhi, 13 March 2013 – Pressure is mounting on India to quickly sign off on a free...
Press Release – Last updated 13 March 2013
msfaccess.org/about-us/media-room/press-releases/india-under-pressure-europe-sign-trade-deal-will-harm-access
